Arpad Z. Barabas

Calgary, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The modified vaccination technique designed to prevent and cure acute and chronic disorders.

The modified vaccination technique designed to prevent and cure acute and chronic disorders.

Journal: Human antibodies

Published: October 09, 2019

Antibody-initiated beneficial and harmful immune responses.

Antibody-initiated beneficial and harmful immune responses.

Journal: Immunologic research

Published: November 21, 2018

The Modified Vaccination Technique.

The Modified Vaccination Technique.

Journal: Vaccines

Published: October 15, 2018

Suppression of tumor growth by a heterologous antibody directed against multiple myeloma dominant CD38 antigen in SCID mice injected with multiple myeloma cells.

Suppression of tumor growth by a heterologous antibody directed against multiple myeloma dominant CD38 antigen in SCID mice injected with multiple myeloma cells.

Journal: Human antibodies

Published: January 28, 2017

A novel modified vaccination technique produces IgG antibodies that cause complement-mediated lysis of multiple myeloma cells carrying CD38 antigen.

A novel modified vaccination technique produces IgG antibodies that cause complement-mediated lysis of multiple myeloma cells carrying CD38 antigen.

Journal: Human antibodies

Published: January 28, 2017

Tolerance, loss of tolerance and regaining tolerance to self by immune-mediated events.

Tolerance, loss of tolerance and regaining tolerance to self by immune-mediated events.

Journal: Immunologic research

Published: July 27, 2016

Regaining tolerance to a self-antigen by the modified vaccination technique.

Regaining tolerance to a self-antigen by the modified vaccination technique.

Journal: Clinical reviews in allergy & immunology

Published: January 09, 2013

Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease.

Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease.

Journal: Autoimmunity

Published: July 24, 2012

Production of heterologous IgG antibody against Heymann nephritis antigen by injections of immune complexes.

Production of heterologous IgG antibody against Heymann nephritis antigen by injections of immune complexes.

Journal: International journal of experimental pathology

Published: November 23, 2011

The role of autoimmunologists in investigating and treating autoimmune disorders.

The role of autoimmunologists in investigating and treating autoimmune disorders.

Journal: Autoimmunity reviews

Published: September 02, 2010

Elevated antibody response by antigen presentation in immune complexes.

Elevated antibody response by antigen presentation in immune complexes.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: January 24, 2007

Antigen-specific down-regulation of immunopathological events in an experimental autoimmune kidney disease.

Antigen-specific down-regulation of immunopathological events in an experimental autoimmune kidney disease.

Journal: Autoimmunity reviews

Published: March 17, 2005

Showing 1-12 of 12

Last Updated: 09/26/2026